Advertisement

Pathology of Cardiac Valve Replacement

  • Frederick J. Schoen

Abstract

Patients with severe valvular heart disease who undergo replacement of one or more cardiac valves have increased survival, enhanced function, and improved quality of life relative to similar patients who have not been operated on (1,2). Despite the success and consequent wide application of this therapy, for an individual patient there is often considerable uncertainty regarding the optimal timing of surgery, appropriate prosthesis to use, and ultimate prognosis (3,4). Progressive myocardial degeneration arising prior to and not correctable by surgery may contribute to early mortality or may be responsible for late deterioration (5). Such damage may undermine the otherwise beneficial effects of hemodynamic adjustment obtained by removal of damaged valves and their replacement by prostheses. Artificial valves may also be associated with important complications.

Keywords

Valve Replacement Heart Valve Prosthetic Valve Prosthetic Heart Valve Valve Prosthesis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kirklin JW, Pacifico AD: Surgery for acquired valvular heart disease. N Engl J Med 288:133–140, 194 – 198, 1973.Google Scholar
  2. 2.
    Rahimtoola SH: Valvular heart disease: a perspective. J Am Coll Cardiol 1: 199 - 215, 1983.PubMedGoogle Scholar
  3. 3.
    Hammermeister KE: Chronic valvular disease in adults-when to operate. J Cardiovasc Med 6: 632 – 655, 1981.Google Scholar
  4. 4.
    Bonow RO, Rosing DR, Kent KM, Epstein SE: Timing of operation for chronic aortic regur-gitation. Am J Cardiol 50: 325–336, 1982.PubMedGoogle Scholar
  5. 5.
    Ferrans VJ: Morphology of heart in hypertrophy. Hosp Pract: 67–78, (July) 1983.Google Scholar
  6. 6.
    Roberts WC: Factors determining outcome of cardiac valve replacement. Ann Thorac Surg 27: 101–103, 1979.PubMedGoogle Scholar
  7. 7.
    Griffiths SP, Zazula BM, Courtney D, Spencer FC, Malm JR: Trends in cardiovascular surgery (1961–1977): review of the New York City and State experience. Am J Cardiol 44: 555–562, 1979.PubMedGoogle Scholar
  8. 8.
    Barnhorst DA, Oxman HA, Connolly DC, Pluth JR, Danielson GK, Wallace RB, McGoon DC: Long-term follow-up of isolated replacement of the aortic or mitral valve with the Starr-Edwards prosthesis. Am J Cardiol 35: 228–233, 1975.PubMedGoogle Scholar
  9. 9.
    Richardson JV, Kouchoukos NT, Wright JO, Karp KB: Combined aortic valve replacement and myocardial revascularization: results in 220 patients. Circulation 59: 75–81, 1979.PubMedGoogle Scholar
  10. 10.
    Lytle BW, Cosgrove DM, Loop FD, Taylor PC, Gill CC, Golding LA, Goormastic M, Groves LK: Replacement of aortic valve combined with myocardial revascularization: determinants of early and late risk for 500 patients, 1967–1981. Circulation 68: 1149–1162, 1983.PubMedGoogle Scholar
  11. 11.
    Roberts WC, Bulkley BH, Morrow AG: Pathologic anatomy of cardiac valve replacement: a study of 224 necropsy patients. Prog Cardiovasc Dis 15: 539–587, 1973.PubMedGoogle Scholar
  12. 12.
    Schoen FJ, Titus JL, Lawrie GM: Autopsy- determined causes of death after cardiac valve replacement. JAMA 249: 899–902, 1983.PubMedGoogle Scholar
  13. 13.
    Schoen FJ, Lawrie GM, Titus JL: Morphology and significance of acute myocardial injury following cardiac valve replacement surgery. Lab Invest 52: 60A, 1985.Google Scholar
  14. 14.
    Bulkley BH, Hutchins GM: Myocardial consequences of coronary artery bypass graft surgery. The paradox of necrosis in areas of revascularization. Circulation 56: 906–913, 1977.Google Scholar
  15. 15.
    Gotlieb A, Masse S, Allard J, Dobel A, Huang SN: Concentric hemorrhagic necrosis of the myocardium. A morphological and clinical study. Human Pathol 8: 27–37, 1977.Google Scholar
  16. 16.
    Braunwald E, Kloner RA: The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 66: 1146–1149, 1982.PubMedGoogle Scholar
  17. 17.
    Schoen FJ, Bernhard WF, Khuri SF, Koster JK, Van Devanter SJ, Weintraub RM: Pathologic findings in postcardiotomy patients managed with a temporary left ventricular assist pump. Am J Surg 143: 508–513, 1982.PubMedGoogle Scholar
  18. 18.
    Pennock JL, Pierce WS, Wisman CB, Bull AP, Waldhausen JA: Survival and complications following ventricular assist pumping for cardiogenic shock. Ann Surg 198: 469–476, 1983.PubMedGoogle Scholar
  19. 19.
    Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD: Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 86: 845–857, 1983.PubMedGoogle Scholar
  20. 20.
    Copeland JG, Griepp RB, Stinson EB, Shumway NE: Long-term follow-up after isolated aortic valve replacement. J Thorac Cardiovasc Surg 74: 875–885, 1977.PubMedGoogle Scholar
  21. 21.
    Salomon NE, Stinson EB, Griepp RB, Shumway NE: Mitral valve replacement: long-term evaluation of prosthesis-related mortality and morbidity. Circulation 56 (suppl II): II94–II101, 1977.Google Scholar
  22. 22.
    Teply JF, Grunkemeier GL, D’Arcy Sutherland H, Lambert LE, Johnson VA, Starr A: The ultimate prognosis after valve replacement: an assessment at twenty years. Ann Thorac Surg 32: 111–119, 1981.PubMedGoogle Scholar
  23. 23.
    Murphy DA, Levine FH, Buckley MJ, Swinski L, Daggett WM, Akins CW, Austen WG: Mechanical valves: a comparative analysis of the Starr-Edwards and Bjork-Shiley prostheses. J Thorac Cardiovasc Surg 86: 746–752, 1983.PubMedGoogle Scholar
  24. 24.
    Starr A, Grunjemeier G, Lambert L, Okies JE, Thomas D: Mitral valve replacement. A 10-year follow-up of non-cloth-covered vs cloth-covered caged-ball prostheses. Circulation 54 (suppl III):III47–III56, 1976.Google Scholar
  25. 25.
    Oyer PE, Stinson EB, Reitz BA, Miller DC, Rossiter DC, Shumway NE: Long-term evaluation of the porcine xenograft bioprosthesis. J Thorac Cardiovasc Surg 78: 343–350, 1979.PubMedGoogle Scholar
  26. 26.
    Joassin A, Edwards JE: Late causes of death after mitral valve replacement: analysis of 36 cases. J Thorac Cardiovasc Surg 65: 225–263, 1973.Google Scholar
  27. 27.
    Cohn LH, Koster JK, VanDevanter S, Collins JJ: The inhospital risk of replacement of dysfunctional mitral and aortic valves. Circulation 66 (suppl I):II53–II56, 1982.Google Scholar
  28. 28.
    Husebye DG, Pluth JR, Piehler JM, Schaff HV, Orszulak TA, Puga FJ, Danielson GK: Reoperation on prosthetic heart valves. An analysis of risk factors in 552 patients. J Thorac Cardiovas Surg 86: 543–551, 1983.Google Scholar
  29. 29.
    Schoen FJ, Hobsen CE: Anatomic analysis of removed prosthetic heart valves: causes of failure of 33 mechanical valves and 58 bioprostheses, 1980 to 1983. Human Pathol 16: 549–559, 1985.Google Scholar
  30. 30.
    Schoen FJ, Lawrie GM, Titus JL: Left ventricular cellular hypertrophy in pressure and volume overload valvular heart disease. Human Pathol 15: 860–865, 1984.Google Scholar
  31. 31.
    Grossman W: Cardiac hypertrophy: useful adaptation or pathologic process. Am J Med 69: 576–584, 1980.PubMedGoogle Scholar
  32. 32.
    Tarazi RC: The progression from hypertrophy to heart failure. Hosp Pract: 101–122 (Aug), 1983.Google Scholar
  33. 33.
    Sunamori M, Suzuki A, Harrison CE: Relationship between left ventricular morphology and postoperative cardiac function following valve replacement for mitral stenosis. J Thorac Cardiovasc Surg 85: 727–732, 1983.PubMedGoogle Scholar
  34. 34.
    Oldershaw PJ, Brooksby IAB, Davies MJ, Coltart DJ, Jenkins BS, Webb-Peploe MM: Correlations of fibrosis in endomyocardial biopsies from patients with aortic valve disease. Br Heart J 44: 609–611, 1980.PubMedGoogle Scholar
  35. 35.
    Slezak J, Geller SA, Litwak RS, Smith H: Long-term study of the ultrastructural changes of myocardium in patients undergoing cardiac surgery, with more than 10 years follow-up. Int J Cardiol 4: 153–168, 1983.PubMedGoogle Scholar
  36. 36.
    Schwarz F, Schaper J, Kittstein D, Flameng W, Walter P, Schaper W: Reduced volume fraction of myofibrils in myocardium of patients with decompensated pressure overload. Circulation 63: 1299–1304, 1981.PubMedGoogle Scholar
  37. 37.
    Fowles RE, Mason JW: Endomyocardial biopsy. Ann Intern Med 97: 885–894, 1982.PubMedGoogle Scholar
  38. 38.
    Behrendt DM, Austen WG: Current status of prosthetics for heart valve replacement. Prog Cardiovasc Dis 15: 369–401, 1973.PubMedGoogle Scholar
  39. 39.
    Austen WG: Heart valve substitutes. In: Johnson RA, Haber E, Austen WG. (eds.) The Practice of Cardiology. Little, Brown and Co., Boston, 1980, pp. 527–569.Google Scholar
  40. 40.
    Boncheck LI: Current status of cardiac valve replacement: selection of a prosthesis and indication for operation. Am Heart J 101: 96–106, 1981.Google Scholar
  41. 41.
    Schoen FJ, Titus JL, Lawrie GM: Bioengineering aspects of cardiac valve replacement. Ann Biomed Engin 10: 97–128, 1982.Google Scholar
  42. 42.
    McClung JA, Stein JH, Ambrose JA, Herman MV, Reed GE: Prosthetic heart valves: a review. Prog Cardiovasc Dis 26: 237–270, 1983.PubMedGoogle Scholar
  43. 43.
    Emery RW, Nicoloff DM: St. Jude medical cardiac valve prosthesis. Invitro studies. J Thorac Cardiovasc Surg 78: 269–276, 1979.PubMedGoogle Scholar
  44. 44.
    Horstkott D, Korfer R, Seipel L, Bircks W, Loogen F: Late complications of patients with Bjork-Shiley and St. Jude Medical heart valve replacement. Circulation 68 (Suppl II):II175–II184, 1983.Google Scholar
  45. 45.
    Titus JL: Pathology of grafted heart valves. Adv Cardiol 7: 149–162, 1972.Google Scholar
  46. 46.
    Cohn LH, Gallucci V (eds.): Cardiac Bioprostheses. Yorke, New York, 1982, p. 1–591.Google Scholar
  47. 47.
    Ionescu MI, Smith DR, Hasan SS, Chidambaram M, Tandon AP: Clinical durability of the pericardial xenograft valve: ten years’ experience with mitral replacement. Ann Thorac Surg 34: 265–276, 1982.PubMedGoogle Scholar
  48. 48.
    Berger K, Sauvage LR, Wood SJ, Wesolowski SA: Sewing ring healing of cardiac valve prostheses. Surgery 61: 102–117, 1967.PubMedGoogle Scholar
  49. 49.
    McGoon DC: Long-term effects of prosthetic materials. Am J Cardiol 50: 621–630, 1982.PubMedGoogle Scholar
  50. 50.
    Kotler MN, Mintz GS, Panidis I, Morganroth J, Segal BL, Ross J: Noninvasive evaluation of normal and abnormal prosthetic valve function. J Am Coll Cardiol 2: 151–173, 1983.PubMedGoogle Scholar
  51. 51.
    Rahimtoola SH: The problem of valve prosthesis-patient mismatch. Circulation 58: 20–24, 1978.PubMedGoogle Scholar
  52. 52.
    Roschke EJ, Harrison EC: Size comparison of commercial prosthetic heart valves. Med Instrum 7: 277–282, 1973.PubMedGoogle Scholar
  53. 53.
    Roberts WC: Complications of cardiac valve replacement: characteristic abnormalities of prostheses pertaining to any or specific site. Am Heart J 103: 113–122, 1982.PubMedGoogle Scholar
  54. 54.
    Williams DB, Pluth JR, Orszulak TA: Extrinsic obstruction of the Bjork-Shiley valve in the mitral position. Ann Thorac Surg 32: 58–62, 1980.Google Scholar
  55. 55.
    Antunes MJ, Colsen PR, Kinsley RH: Intermittent aortic regurgitation following aortic valve replacement with the Hall-Kaster prosthesis. J Thorac Cardiovasc Surg 84: 751–754, 1982.PubMedGoogle Scholar
  56. 56.
    Ziemer G, Luhmer I, Oelert H, Borst HG: Malfunction of a St. Jude medical heart valve in mitral position. Ann Thorac Surg 33: 391–395, 1982.PubMedGoogle Scholar
  57. 57.
    Arrigoni MG, Pluth JR, Danielson GK, Titus JL: Stuck aortic poppet. A hazard of close- clearance cloth-covered prosthetic aortic valves. JAMA 219: 183–185, 1972.PubMedGoogle Scholar
  58. Theine G, Arbustini E, Bortolotti U, Talenti E, Milano A, Valente M, Molin G, Gallucci V: Pathologic substrates of porcine valve dysfunction. In: Cohn LH, Gallucci V (eds.) Cardiac Bioprostheses, Yorke, New York, pp. 378–400.Google Scholar
  59. 59.
    Bernstein EF: Certain aspects of blood inter- facial phenomena-red blood cells. Fed Proc 30: 1510–1515, 1971.PubMedGoogle Scholar
  60. 60.
    Roberts WC, Morrow AG: Renal hemosiderosis in patients with prosthetic heart valves. Circulation 33: 390 - 398, 1966.PubMedGoogle Scholar
  61. 61.
    Harrison EC, Roschke EJ, Meyer HI, Edmiston WA, Chan LS, Tatter D, Lau FK. Cholelithiasis: a frequent complication of artificial heart valve replacement. Am Heart J 95: 483–488, 1978.PubMedGoogle Scholar
  62. 62.
    Clark RE, Pavolovic TA, Knight BE, Joist JH, Durrows SD, McKnight RC, Brown EB: Quantification of wear, hemolysis and coagulation deficits in patients with Beall mitral valves. Circulation 56 (suppl II):II139–II143, 1977.Google Scholar
  63. 63.
    Lader E, Kronzon I, Trehan N, Colvin S, Newman W, Roseffe I: Severe hemolytic anemia in patients with a porcine aortic valve prosthesis. J Am Coll Cardiol 1: 1174–1176, 1983.PubMedGoogle Scholar
  64. 64.
    Dhasmana JP, Blackstone EH, Kirklin JW, Kouchoukos NT: Factors associated with periprosthetic leakage following primary mitral valve replacement: with special consideration of the suture technique. Ann Thorac Surg 35: 170–178, 1983.PubMedGoogle Scholar
  65. 65.
    Edmunds LH: Thromboembolic complications of current cardiac valvular prostheses. Ann Thorac Surg 34: 96–106, 1982.PubMedGoogle Scholar
  66. 66.
    Fuster V, Pumphrey CW, McGoon MD, Chesebro JH, Pluth JR, McGoon DC: Systemic thromboembolism in mitral and aortic Starr- Edwards prostheses: a 10–19-year follow-up. Circulation 66 (suppl I): I157–I161, 1982.PubMedGoogle Scholar
  67. 67.
    Miller DC, Oyer PE, Stinson EB, Reitz BA, Jamieson SW, Baumgartner WA, Mitchell RS, Shumway NE: Ten to fifteen year reassessment of the performance characteristics of the Starr-Edwards model 6120 mitral valve prosthesis. J Thorac Cardiovasc Surg 85: 1–20, 1983.PubMedGoogle Scholar
  68. 68.
    Yoganathan AP, Reamer HH, Corcoran WH, Harrison EC, Shulman IA, Parnassus W: The Starr-Edwards aortic ball valve: flow characteristics, thrombus formation, and tissue ov-ergrowth, Artif Organs 5: 6–17, 1981.PubMedGoogle Scholar
  69. 69.
    Yoganathan AP, Corcoran WH, Harrison EC, Carl JR: The Bjork-Shiley aortic prosthesis: flow characteristics, thrombus formation and tissue overgrowth. Circulation 58: 70 - 76, 1978.PubMedGoogle Scholar
  70. 70.
    Duvoisin GE, Brandenburg RO, McGoon DC: Factors affecting thromboembolism associated with prosthetic heart valves. Circulation 55 (suppl I): I70–I76, 1967.Google Scholar
  71. 71.
    Cohn LH, Mudge GH, Pratter F, Collins JJ: Five to eight-year follow-up of patients undergoing porcine heart-valve replacement. N Engl J Med 304: 258–262, 1981.PubMedGoogle Scholar
  72. 72.
    Wolf PA, Dawber TR, Thomas HE, Kannel WB: Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 28: 973–977, 1978.PubMedGoogle Scholar
  73. 73.
    Gajewski J, Singer RB: Mortality in an insured population with atrial fibrillation. JAMA 245: 1540–1544, 1981.PubMedGoogle Scholar
  74. 74.
    Kelton JG, Hirsh J: Bleeding associated with antithrombotic therapy. Semin Hematol 17: 259–291, 1980.PubMedGoogle Scholar
  75. 75.
    Fuster V, Chesbro: Antithrombotic therapy: role of platelet-inhibitor drugs. I. Current concepts of thrombogenesis: role of platelets. Mayo Clin Proc 56: 102–112, 1981.PubMedGoogle Scholar
  76. 76.
    Chesebro JH, Fuster V, Elveback LR, McGoon DC, Pluth JR, Puga FJ, Wallace RB, Danielson GK, Orszulak TA, Piehler JM, Schaff HV: Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol 51: 1537–1541, 1983.PubMedGoogle Scholar
  77. 77.
    Shattil SJ, Brass LF: The prevention of prosthetic valve thromboembolism. Uses and limitations of anti-platelet drugs. Int J Cardiol 3: 87–91, 1983.PubMedGoogle Scholar
  78. 78.
    Nunez L, Aguado MG, Larrea JL, Celemin D, Oliver J: Prevention of thromboembolism using aspirin after mitral valve replacement with porcine bioprosthesis. Ann Thorac Surg 37: 84, 1984.PubMedGoogle Scholar
  79. 79.
    Watanakunakorn C: Prosthetic valve infective endocarditis. Prog Cardiovasc Dis 22: 181–192, 1979.PubMedGoogle Scholar
  80. 80.
    Wilson WR, Danielson GK, Giuliani ER, Geraci JE: Prosthetic valve endocarditis. Mayo Clin Proc 57: 155–161, 1982.PubMedGoogle Scholar
  81. 81.
    Mayer KH, Schoenbaum SC: Evaluation and management of prosthetic valve endocarditis. Prog Cardiovasc Dis 25: 43–54, 1982.PubMedGoogle Scholar
  82. 82.
    Ivert TS, Dismukes WE, Cobbs CG, Blackstone EH, Kirklin JW, Bergdahl LA: Prosthetic valve endocarditis. Circulation 69: 223–232, 1984.PubMedGoogle Scholar
  83. 83.
    Karchmer AW, Dismukes WE, Buckley MJ, Austen WG: Late prosthetic valve endocarditis. Clinical features influencing therapy. Am J Med 64: 199–206, 1978.PubMedGoogle Scholar
  84. 84.
    Karchmer AW, Archer GL, Dismukes WE: Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med 98: 447–455, 1983.PubMedGoogle Scholar
  85. 85.
    Rae T: Localized tissue infection and the influence of foreign bodies. In: Williams DF (ed.) Fundamental Aspects of Biocompatibility, Vol. II, CRC Press, Boca Raton, Fl, 1981, pp. 155–161.Google Scholar
  86. 86.
    Arnett EN, Roberts WC: Prosthetic valve endocarditis. Clinicopathologic analysis of 22 necropsy patients with comparison of observations in 74 necropsy patients with active infective endocarditis involving natural left-sided cardiac valves. Am J Cardiol 38: 281–292, 1976.PubMedGoogle Scholar
  87. 87.
    Anderson DJ, Bulkley BH, Hutchins GM: A clinicopathologic study of prosthetic valve endocarditis in 22 patients: morphologic basis for diagnosis and therapy. Am Heart J 94: 324–332, 1977.Google Scholar
  88. 88.
    Baumgartner WA, Miller DC, Reitz BA, Oyer PE, Jamieson SW, Stinson EB, Shumway NE: Surgical treatment of prosthetic valve endocarditis. Ann Thorac Surg 35: 87–102, 1983.PubMedGoogle Scholar
  89. 89.
    Ferrans VJ, Boyce SW, Billingham ME, Spray TL, Roberts WC: Infection of glutaraldehyde-preserved porcine valve heterografts. Am J Cardiol 43: 1123–1135, 1979.PubMedGoogle Scholar
  90. 90.
    Rossiter SJ, Stinson EB, Oyer PE, Muller DC, Schapira JN, Martin RP, Shumway NE: Prosthetic valve endocarditis: a comparison of heterograft tissue valves and mechanical valves. J Thorac Cardiovas Surg 76: 795–802, 1980.Google Scholar
  91. 91.
    Schoen FJ, Collins J J, Cohn LH: Long-term failure rate and morphologic correlations in porcine bioprosthetic heart valves. Am J Cardiol 51: 957–964, 1983.PubMedGoogle Scholar
  92. 92.
    Bortolotti U, Thiene G, Milano A, Panizzon G, Valente M, Gallucci V: Pathological study of infective endocarditis on Hancock porcine bioprotheses. J Thorac Cardiovasc Surg 81: 934–942, 1981.PubMedGoogle Scholar
  93. 93.
    Schoen FJ, Levy RJ: Bioprosthetic heart valve failure: pathology and pathogenesis. Cardiol Clin 2: 717–739, 1984.PubMedGoogle Scholar
  94. 94.
    Milano A, Bortolotti U, Talenti E, Valfre C, Arbustini E, Valente M, Mazzucco A, Gullucci V, Thiene G: Calcific degeneration as the main cause of porcine bioprosthetic valve failure. Am J Cardiol 53: 1066–1070, 1984.PubMedGoogle Scholar
  95. 95.
    Marbarger JP, Clark RE: The clinical life history of explanted prosthetic heart valves. Ann Thorac Surg 34: 22–33, 1982.PubMedGoogle Scholar
  96. 96.
    Hylen JC, Kloster FE, Starr A, Griswold HE: Aortic ball variance: diagnosis and treatment. Ann Intern Med 72: 1–8, 1970.PubMedGoogle Scholar
  97. 97.
    Shah A, Dolgin AM, Tice DA, Trehan N: Complications due to cloth wear in cloth-covered Starr-Edwards aortic and mitral valve prosthesis-and their management. Am Heart J 96: 407–414, 1978.PubMedGoogle Scholar
  98. 98.
    Schoen FJ, Goodenough SH, Ionescu MI, Braunwald NS: Implications of late morphology of Braunwald-Cutter mitral heart valve prostheses. J Thorac Cardiovasc Surg 88: 208–216, 1984.PubMedGoogle Scholar
  99. 99.
    Warnes CA, Scott ML, Silver GM, Smith CW, Ferrans VJ, Roberts WC: Comparison of late degenerative changes in porcine bioprostheses in the mitral and aortic valve position in the same patient. Am J Cardiol 51: 965–968, 1983.PubMedGoogle Scholar
  100. 100.
    Roberts WC, Hammer WJ: Cardiac pathology after valve replacement with a tilting-disk prosthesis (Bjork-Shiley type): a study of 46 necropsy patients and 49 Bjork-Shiley prostheses. Am J Cardiol 37: 1024–1033, 1976.PubMedGoogle Scholar
  101. 101.
    Hylen JC, Hodam RP, Kloster FE: Changes in the durability of silicone rubber in ball- valve prostheses. Ann Thorac Surg 13: 324–329, 1972.PubMedGoogle Scholar
  102. 102.
    Smithwick W, Kouchoukos NT, Karp RB, Pacifico AD, Kirklin JW: Late stenosis of Starr- Edwards cloth-covered prostheses. Ann Thorac Surg 20: 249–254, 1975.PubMedGoogle Scholar
  103. 103.
    Roberts WC, Fishbein MC, Golden A: Cardiac pathology after valve replacement by disk prosthesis. A study of 61 necropsy patients. Am J Cardiol 35: 740–760, 1975.PubMedGoogle Scholar
  104. 104.
    Silver MD, Wilson GJ: The pathology of wear in the Beall model 104 heart valve prosthesis. Circulation 56: 617–622, 1977.PubMedGoogle Scholar
  105. 105.
    Silver MD: Wear in Bjork-Shiley heart valve prostheses recovered at necropsy or operation. J Thorac Cardiovasc Surg 79: 693–699, 1980.PubMedGoogle Scholar
  106. 106.
    Roe BB, Fishman NH, Hutchins JC, Goodenough SH: Occluder disruption of Wada- Cutter valve prostheses. Ann Thorac Surg 20: 256–264, 1975.PubMedGoogle Scholar
  107. 107.
    Ridolfi RL, Hutchins GM: Detection of ball variance in prosthetic heart valves by liver biopsy. Johns Hopkins Med J 134: 131–140, 1974.PubMedGoogle Scholar
  108. 108.
    Schoen FJ: Carbon in heart valve prostheses: foundations and clinical performance. In: Szycher ML (ed.) Biocompatible Polymers, Metals and Ceramics: Science and Technology. Technomic Publishing Co., Westport, Conn., 1983, pp. 239–261.Google Scholar
  109. 109.
    Schoen FJ, Titus JL, Lawrie GM: Durability of pyrolytic carbon-containing heart valve prostheses. J Biomed Mater Res 16: 559–570, 1982.PubMedGoogle Scholar
  110. 110.
    Norenberg DD, Evans RW, Gundersen AE, Abellera RM: Fracture and embolization of a Bjork-Shiley disc. Fatal failure of a prosthetic mitral valve. J Thorac Cardiovasc Surg 74: 924–927, 1977.Google Scholar
  111. 111.
    Larrieu AJ, Puglia E, Allen P: Strut fracture and disc embolization of a Bjork-Shiley mitral valve prosthesis: localization of embolized disc by computerized axial tomography. Ann Thorac Surg 34: 192–195, 1982.PubMedGoogle Scholar
  112. 112.
    Braunwald NS, Morrow AG: A late evaluation of flexible Teflon prostheses utilized for total aortic valve replacement. J Thorac Cardiovas Surg 49: 485–496, 1965.Google Scholar
  113. 113.
    Fishbein MC, Roberts WC, Golden A, Hufnagel CA: Cardiac pathology after valve replacement using Hufnagel trileaflet prostheses: a study of 20 necropsy patients. Am Heart J 89: 443–448, 1975.PubMedGoogle Scholar
  114. 114.
    Russell FB, Lederman DM, Singh PI, Cumming RD, Morgan RA, Levine FH, Austen WG, Buckley MJ: Development of seamless tri-leaflet valves. Trans Am Soc Artif Intern Organs 26: 66–70, 1980.PubMedGoogle Scholar
  115. 115.
    Wisman CB, Pierce WS, Donachy JH, Pae WE, Myers JL, Prophet GA: A polyurethane trileaflet cardiac valve prosthesis: in vitro and in vivo studies. Trans Am Soc Artif Intern Organs 28: 164–168, 1982.PubMedGoogle Scholar
  116. 116.
    Oyer PE, Miller DC, Stinson EB, Reitz BA, Moreno-Cabral RJ, Shumway NE: Clinical durability of the Hancock porcine bioprosthetic valve. J Thorac Cardiovasc Surg 80: 824–833, 1980.PubMedGoogle Scholar
  117. 117.
    Lakier JB, Khaja F, Magilligan DJ, Goldstein S: Porcine xenograft valves. Long-term (60–89 months) follow-up. Circulation 62: 313–319, 1980.PubMedGoogle Scholar
  118. 118.
    Walker WE, Duncan JM, Frazier OH, Livesay JJ, Ott DA, Reul FJ, Cooley DA: Early experience with the Ionescu-Shiley pericardial xenograft valve. Accelerated calcification in children. J Thorac Cardiovasc Surg 86: 570–575, 1983.PubMedGoogle Scholar
  119. 119.
    Gabbay S, Bortolotti U, Wasserman F, Tindel N, Factor SM, Frater RW: Long-term follow- up of the Ionescu-Shiley mitral pericardial xenograft. J Thorac Cardiovasc Surg 88: 758–763, 1984.PubMedGoogle Scholar
  120. 120.
    Ishihara T, Ferrans VJ, Boyce SW, Jones M, Roberts WC: Structure and classification of cuspal tears and perforations in porcine bio-prosthetic cardiac valves implanted in patients. Am J Cardiol 48: 665–678, 1981.PubMedGoogle Scholar
  121. 121.
    Pomar JL, Bosch X, Chaitman BR, Pelletier C, Grondin CM: Late tears in leaflets of porcine bioprostheses in adults. Ann Thorac Surg 37: 78–83, 1984.PubMedGoogle Scholar
  122. 122.
    Ferrans VJ, Boyce SW, Billingham ME, Jones J, Ishihara T, Roberts WC: Calcific deposits in porcine bioprostheses: structure and pathogenesis. Am J Cardiol 46: 721–734, 1980.PubMedGoogle Scholar
  123. 123.
    Forfar JC, Cotter L, Morrett GN: Severe and early stenosis of porcine heterograft mitral valve. Br Heart J 40: 1184–1187, 1978.PubMedGoogle Scholar
  124. 124.
    Ishihara T, Ferrans VJ, Jones M, Cabin HS, Roberts WC: Calcific deposits developing in a bovine pericardial bioprosthetic valve 3 days after implantation. Circulation 63: 718–723, 1981.PubMedGoogle Scholar
  125. 125.
    Thubrikar MJ, Deck JD, Aouad J, Nolan SP: Role of mechanical stress in calcification of aortic bioprosthetic valves. J Thorac Cardiovasc Surg 86: 115–125, 1983.PubMedGoogle Scholar
  126. 126.
    Sanders SP, Levy RJ, Freed MD, Norwood WI, Castaneda AR: Use of Hancock porcine xenografts in children and adolescents. Am J Cardiol 46: 429–438, 1980.PubMedGoogle Scholar
  127. 127.
    Miller DC, Stinson EB, Oyer PE, Billingham ME, Pitlick PT, Reitz BA, Jamieson SW, Baumgartner WA, Shumway NE: The durability of porcine xenograft valves and conduits in children. Circulation (suppl I ) 66: 1172–1185, 1982.Google Scholar
  128. 128.
    Broom ND: Fatigue-induced damage in glutaraldehyde-preserved heart valve tissue. J Thorac Cardiovasc Surg 76: 202–211, 1978.PubMedGoogle Scholar
  129. 129.
    Wright JT, Eberhardt CE, Gibbs ML, Saul T, Gilpin CB: Hancock II-an improved bioprosthesis. In: Cohn LH, Gallucci V, (eds.) Cardiac Bioprostheses. Yorke, New York, 1982, pp. 425–444.Google Scholar
  130. 130.
    Bodnar E, Bowden NL, Drury PJ, Olsen EG, Durmaz I, Ross DN: Biscupid mitral bioprosthesis. Thorax 36: 45–51, 1981.PubMedGoogle Scholar
  131. 131.
    Gabbay S, Frater RW: The unileaflet heart valve bioprosthesis: new concept. In: Cohn LH, Gallucci V (eds.) Cardiac Bioprostheses. Yorke, New York, 1982, pp. 411–424.Google Scholar
  132. 132.
    Barnhart GR, Jones M, Ishihara T, Chavez AM, Rose DM, Ferrans VJ: Bioprosthetic valvular failure. Clinical and pathological observations in an experimental animal model. J Thorac Cardiovasc Surg 83: 618–631, 1982.PubMedGoogle Scholar
  133. 133.
    Levy RJ, Zenker JA, Bernhard WF: Porcine bioprosthetic valve calcification in bovine left ventricle-aorta shunts: Studies of the deposition of vitamin K-dependent proteins. Ann Thorac Surg 36: 187–192, 1983.PubMedGoogle Scholar
  134. 134.
    Levy RJ, Schoen FJ, Howard SL: Mechanism of calcification of porcine bioprosthetic aortic valve cusps: Role of T-lymphocytes. Am J Cardiol 52: 629–631, 1983.PubMedGoogle Scholar
  135. 135.
    Levy RJ, Schoen FJ, Levy JT, Nelson AC, Howard SL, Oshry LJ: Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol 113: 143–155, 1983.PubMedGoogle Scholar
  136. 136.
    Fishbein MC, Levy RJ, Ferrans VJ, Dearden LC, Nashef A, Goodman AP, Carpentier A: Calcification of cardiac valve bioprostheses. Biochemical, histologic and ultrastructural observations in a subcutaneous implantation model system. J Thorac Cardiovasc Surg 83: 602–609, 1982.PubMedGoogle Scholar
  137. 137.
    Rocchini AP, Weesner KM, Heidelberger K, Keren D, Behrendt D, Rosenthal A: Porcine xenograft valve failure in children: An immunologic response. Circulation 64 (suppl II): II162–II171, 1981.Google Scholar
  138. 138.
    Schoen FJ, Levy RJ, Nelson AC, Bernhard WF, Nashef A, Hawley M: Onset and progression of experimental bioprosthetic heart valve calcification. Lab Invest 52: 523–532, 1985.PubMedGoogle Scholar
  139. 139.
    Schoen FJ, Tsao JW, Levy RJ: Bovine pericardial bioprosthetic heart valve cusps calcify equivalently to those derived from porcine aortic valves. Transactions, Society for Bio- materials 8: 190, 1985.Google Scholar
  140. 140.
    Levy RJ, Hawley MA, Schoen FJ, Lund SA, Liu PY: Inhibition by diphosphonate compounds of calcification of porcine bioprosthetic heart valve cusps implanted subcutaneously in rats. Circulation 71: 349–356, 1985.PubMedGoogle Scholar
  141. 141.
    Levy RJ, Wolfrum J, Schoen FJ, Hawley MA, Lund SA, Langer R: Inhibition of calcification of bioprosthetic heart valves by local controlled-released diphosphonate. Science 227: 190–192, 1985.Google Scholar
  142. 142.
    Lentz DJ, Pollock EM, Olsen DB, Andrews EJ: Prevention of intrinsic calcification in porcine and bovine xenograft materials. Trans Am Soc Artif Intern Organs 28: 494–497, 1982.PubMedGoogle Scholar
  143. 143.
    Arbustini EI, Jones M, Moses RD, Eidbo EE, Carroll RJ, Ferrans VJ: Modification by the Hancock T6 Process of calcification of bioprosthetic cardiac valves implanted in sheep. Am J Cardiol 53: 1388–1396, 1984.PubMedGoogle Scholar
  144. 144.
    Silver MD, Datta BN, Bowes VF: A key to identify heart valve prostheses. Arch Pathol 99: 132–128, 1975.PubMedGoogle Scholar
  145. 145.
    Silver MD, Wilson GJ: Pathology of cardiovascular prostheses including coronary artery bypass and other vascular grafts. In: Silver MD (ed.) Cardiovascular Pathology. Churchill-Livingstone, New York, 1983, pp. 1225- 1296.Google Scholar
  146. 146.
    Mehlman DJ: A guide to the radiographic identification of prosthetic heart valves: an addendum. Circulation 69: 102 - 105, 1984.PubMedGoogle Scholar
  147. Chin HP, Harrison EC, Blankenhorn DH, Moacanin J: Lipids in silicone rubber valve prostheses after human implantation. Circu-lation 43/44 (suppl I): I51–I56, 1971.Google Scholar
  148. 148.
    McDowell EM, Trump BF: Histologic fixatives suitable for diagnostic light and electron microscopy. Arch Pathol Lab Med 100: 405–414, 1976.PubMedGoogle Scholar
  149. 149.
    Borkon AM, Mcintosh CL, Jones M, Roberts WC, Morrow AG: Inward stent-post bending of a porcine bioprosthesis in the mitral position. J Thorac Cardiovasc Surg 83: 105–107, 1982.PubMedGoogle Scholar
  150. 150.
    Borkon AM, Mcintosh CL, Jones M, Roberts WC, Morrow AG: Inward stent-post bending of a porcine bioprosthesis in the mitral position. J Thorac Cardiovasc Surg 83: 105–107, 1982.PubMedGoogle Scholar
  151. 151.
    Cipriano PR, Billingham ME, Oyer PE, Kutsche LM, Stinson EB: Calcification of porcine prosthetic heart valves: a radiographic and light microscopic study. Circulation 66: 1100–1104, 1982.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1985

Authors and Affiliations

  • Frederick J. Schoen

There are no affiliations available

Personalised recommendations